United States Pharmaceuticals

Opus Genetics Inc (IRD)

Track

Track

Opus Genetics Inc. experienced significant insider selling over the past quarter, totaling approximately $2.84 million in net value. Key executives and major shareholders offloaded shares following the company's recent earnings report. Despite these divestments, the stock price has appreciated by 25.9% over the last ninety days, reflecting broader market performance trends.
Ticker: IRD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Opus Genetics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Gagnon Robert E. Chief Financial Officer Officer
Transaction date
Planned sale
Price
298.91
Quantity 32,862 -14.7%
Value US$3,702,158
3.1
Gagnon Robert E. Officer Officer
Transaction date
Proposed sale
Price
368.48
Quantity 61,893
Value US$1,190,401
3.7
YERXA BENJAMIN R President Executive Director
Transaction date
Sale
Price
2.97
Quantity 7,429 -1.0%
Value US$22,064
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Sale
Price
2.94
Quantity 4,644 -1.6%
Value US$13,653
3.1
Gagnon Robert E. Chief Financial Officer Officer
Transaction date
Sale
Price
2.95
Quantity 7,783 -1.3%
Value US$22,942
3.5
Magrath George Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.95
Quantity 9,475 -0.5%
Value US$27,926
3.1
Gagnon Robert E. Officer Officer
Transaction date
Proposed sale
Price
3.05
Quantity 7,783
Value US$23,738
3.5
Magrath George Officer Officer
Transaction date
Proposed sale
Price
3.05
Quantity 9,475
Value US$28,899
3.1
SCHACHLE JOSEPH K Officer Officer
Transaction date
Proposed sale
Price
2.94
Quantity 4,644
Value US$13,653
3.7
YERXA BENJAMIN R Officer Officer
Transaction date
Proposed sale
Price
2.97
Quantity 7,429
Value US$22,064
3.7
YERXA BENJAMIN R President Executive Director
Transaction date
Sale
Price
5.24
Quantity 7,470 -1.0%
Value US$39,121
3.1
Gagnon Robert E. Chief Financial Officer Officer
Transaction date
Sale
Price
5.18
Quantity 7,842 -1.3%
Value US$40,658
3.5
Magrath George Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.22
Quantity 9,511 -0.5%
Value US$49,647
3.2
Zaremba Rabourn Amy Head of Fin. Quality Assurance Officer
Transaction date
Sale
Price
5.20
Quantity 1,641 -0.9%
Value US$8,540
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Sale
Price
5.22
Quantity 4,697 -1.6%
Value US$24,519
3.3
Jayagopal Ashwath Chief Scientific & Dev. Ofc. Officer
Transaction date
Sale
Price
5.19
Quantity 7,542 -1.5%
Value US$39,156
3.1
SCHACHLE JOSEPH K Officer Officer
Transaction date
Proposed sale
Price
5.22
Quantity 4,697
Value US$24,519
3.7
YERXA BENJAMIN R Officer Officer
Transaction date
Proposed sale
Price
5.24
Quantity 7,470
Value US$39,121
3.5
Magrath George Officer Officer
Transaction date
Proposed sale
Price
13.39
Quantity 9,511
Value US$127,327
3.1
Gagnon Robert E. Officer Officer
Transaction date
Proposed sale
Price
5.18
Quantity 7,842
Value US$40,658
3.3
Jayagopal Ashwath Officer Officer
Transaction date
Proposed sale
Price
5.19
Quantity 7,542
Value US$39,156
3.2
Zaremba Rabourn Amy Head of Fin. Quality Assurance Officer
Transaction date
Sale
Price
5.25
Quantity 2,816 -1.5%
Value US$14,770
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Sale
Price
5.25
Quantity 3,719 -1.2%
Value US$19,525
3.5
Magrath George Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.21
Quantity 24,438 -1.4%
Value US$127,327
3.3
Jayagopal Ashwath Chief Scientific & Dev. Ofc. Officer
Transaction date
Sale
Price
5.12
Quantity 3,719 -0.7%
Value US$19,046
3.5
Magrath George Officer Officer
Transaction date
Proposed sale
Price
5.21
Quantity 24,438
Value US$127,327
3.4
Gallagher Cam Non-Executive Director
Transaction date
Purchase
Price
1.97
Quantity 83,000 +inf%
Value US$163,419
3.4
Gallagher Cam Non-Executive Director
Transaction date
Purchase
Price
1.98
Quantity 81,000 +4.5%
Value US$160,275
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
0.98
Quantity 100,000 +20.0%
Value US$97,600
3.7
YERXA BENJAMIN R President Executive Director
Transaction date
Purchase
Price
0.98
Quantity 10,000 +3.0%
Value US$9,834
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.02
Quantity 9,706 +2.0%
Value US$9,943
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.01
Quantity 90,294 +23.0%
Value US$91,215
3.3
Jayagopal Ashwath Chief Scientific & Dev. Ofc. Officer
Transaction date
Purchase
Price
1.77
Quantity 3,500 +4.7%
Value US$6,178
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.75
Quantity 5,000 +1.2%
Value US$8,772
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.75
Quantity 5,000 +1.2%
Value US$8,772
0.7
Jhaveri Nirav S. Chief Financial Officer Officer
Transaction date
Purchase
Price
2.10
Quantity 10,000 +7.1%
Value US$21,000
3.1
SCHACHLE JOSEPH K Chief Operating Officer Officer
Transaction date
Purchase
Price
2.05
Quantity 2,000 +inf%
Value US$4,100
3.5
Magrath George Chief Executive Officer Officer
Transaction date
Purchase
Price
1.96
Quantity 25,000 +6.2%
Value US$49,050
3.4
MANUSO JAMES S J Non-Executive Director
Transaction date
Purchase
Price
1.99
Quantity 5,000 +30.2%
Value US$9,950
2.8
Sooch Mina President and CEO Executive Director
Transaction date
Purchase
Price
2.02
Quantity 12,500 +3.0%
Value US$25,300
2.8
Sooch Mina President and CEO Executive Director
Transaction date
Purchase
Price
2.07
Quantity 12,500 +3.1%
Value US$25,879
1.4
Pepose Jay Non-Executive Director
Transaction date
Purchase
Price
3.65
Quantity 8,250 +56.0%
Value US$30,112
3.4
MANUSO JAMES S J Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 2,000 +13.7%
Value US$7,000
3.4
Gallagher Cam Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 8,865
Value US$0
3.4
MANUSO JAMES S J Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 4,434
Value US$0
2.8
Sooch Mina President and CEO Executive Director
Transaction date
Purchase
Price
0.00
Quantity 11,524
Value US$0
Rodgers Richard J Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 17,730
Value US$0
Ainsworth Sean Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 8,865
Value US$0
MEYER ALAN R Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 1,771
Value US$0
0.6
Beever Charles
Transaction date
Purchase
Price
0.64
Quantity 10,000 +1000.0%
Value US$6,380
0.6
Nolan Lisa Chief Business Officer
Transaction date
Purchase
Price
0.65
Quantity 20,000 +1230.8%
Value US$12,960
0.6
Price Ben Gil
Transaction date
Purchase
Price
0.61
Quantity 15,000 +inf%
Value US$9,141
1.2
Swirsky Douglas J President and CEO
Transaction date
Purchase
Price
0.63
Quantity 50,000 +inf%
Value US$31,720
Ahn Chang Ho
Transaction date
Planned sale
Price
0.70
Quantity 250,000 -4.0%
Value US$175,375
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.91
Quantity 49,800 -9.0%
Value US$45,492
Ahn Chang Ho Non-Executive Director
Transaction date
Planned sale
Price
0.91
Quantity 48,444 -0.8%
Value US$44,263
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.92
Quantity 188,690 -27.2%
Value US$172,708
Ahn Chang Ho Non-Executive Director
Transaction date
Planned sale
Price
0.92
Quantity 186,212 -3.0%
Value US$170,477
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.90
Quantity 78,782 -13.5%
Value US$70,935
Ahn Chang Ho Non-Executive Director
Transaction date
Planned sale
Price
0.90
Quantity 80,000 -1.3%
Value US$72,032
Ahn Chang Ho Non-Executive Director
Transaction date
Sale
Price
0.99
Quantity 136,193 -2.0%
Value US$134,436
Jeong Tae Heum Chief Financial Officer Officer
Transaction date
Sale
Price
0.46
Quantity 71,139 -12.3%
Value US$32,475
Kivel Richard Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 2,500 +inf%
Value US$2,600
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.23
Quantity 5,000 +3.4%
Value US$6,150
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.22
Quantity 13,300 +10.1%
Value US$16,213
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.22
Quantity 55,100 +71.9%
Value US$67,222
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.21
Quantity 6,600 +9.4%
Value US$7,986
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.08
Quantity 15,000 +27.3%
Value US$16,185
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.10
Quantity 2,500 +4.8%
Value US$2,748
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.09
Quantity 5,912 +12.7%
Value US$6,444
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.10
Quantity 13,800 +42.1%
Value US$15,180
Brandt Peter C. Non-Executive Director
Transaction date
Purchase
Price
1.12
Quantity 7,200 +28.1%
Value US$8,064
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-09-30 S Sale
2.2
Foundation Fighting Blindness Retinal Degeneration Fund

See Remarks

Non-Executive Director
85,132 -37.4%
192.52
US$1,670,217 		85,132 -37.4% 192.52 US$1,670,217
2026-09-08 2026-09-03 PlS Planned sale
3.1
Gagnon Robert E.

Chief Financial Officer

Officer
32,862 -14.7%
298.91
US$3,702,158 		32,862 -14.7% 298.91 US$3,702,158
2026-09-03 2026-09-03 PrS Proposed sale
3.1
Gagnon Robert E.

Officer

Officer
61,893
368.48
US$1,190,401 		61,893 368.48 US$1,190,401
2026-07-27 2026-07-23 S Sale
3.7
YERXA BENJAMIN R

President

Executive Director
7,429 -1.0%
2.97
US$22,064 		7,429 -1.0% 2.97 US$22,064
2026-07-27 2026-07-23 S Sale
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
4,644 -1.6%
2.94
US$13,653 		4,644 -1.6% 2.94 US$13,653
2026-07-27 2026-07-23 S Sale
3.1
Gagnon Robert E.

Chief Financial Officer

Officer
7,783 -1.3%
2.95
US$22,942 		7,783 -1.3% 2.95 US$22,942
2026-07-27 2026-07-23 S Sale
3.5
Magrath George

Chief Executive Officer

Executive Director
9,475 -0.5%
2.95
US$27,926 		9,475 -0.5% 2.95 US$27,926
2026-07-23 2026-07-23 PrS Proposed sale
3.1
Gagnon Robert E.

Officer

Officer
7,783
3.05
US$23,738 		7,783 3.05 US$23,738
2026-07-23 2026-07-23 PrS Proposed sale
3.5
Magrath George

Officer

Officer
9,475
3.05
US$28,899 		9,475 3.05 US$28,899
2026-07-23 2026-07-23 PrS Proposed sale
3.1
SCHACHLE JOSEPH K

Officer

Officer
4,644
2.94
US$13,653 		4,644 2.94 US$13,653
2026-07-23 2026-07-23 PrS Proposed sale
3.7
YERXA BENJAMIN R

Officer

Officer
7,429
2.97
US$22,064 		7,429 2.97 US$22,064
2026-05-20 2026-05-18 S Sale
2.2
Foundation Fighting Blindness Retinal Degeneration Fund

See Remarks

Non-Executive Director
1,700,000 -31.0%
4.35
US$7,395,000 		1,700,000 -31.0% 4.35 US$7,395,000
2026-04-27 2026-04-23 S Sale
3.7
YERXA BENJAMIN R

President

Executive Director
7,470 -1.0%
5.24
US$39,121 		7,470 -1.0% 5.24 US$39,121
2026-04-27 2026-04-23 S Sale
3.1
Gagnon Robert E.

Chief Financial Officer

Officer
7,842 -1.3%
5.18
US$40,658 		7,842 -1.3% 5.18 US$40,658
2026-04-27 2026-04-23 S Sale
3.5
Magrath George

Chief Executive Officer

Executive Director
9,511 -0.5%
5.22
US$49,647 		9,511 -0.5% 5.22 US$49,647
2026-04-27 2026-04-23 S Sale
3.2
Zaremba Rabourn Amy

Head of Fin. Quality Assurance

Officer
1,641 -0.9%
5.20
US$8,540 		1,641 -0.9% 5.20 US$8,540
2026-04-27 2026-04-23 S Sale
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
4,697 -1.6%
5.22
US$24,519 		4,697 -1.6% 5.22 US$24,519
2026-04-27 2026-04-23 S Sale
3.3
Jayagopal Ashwath

Chief Scientific & Dev. Ofc.

Officer
7,542 -1.5%
5.19
US$39,156 		7,542 -1.5% 5.19 US$39,156
2026-04-23 2026-04-23 PrS Proposed sale
3.1
SCHACHLE JOSEPH K

Officer

Officer
4,697
5.22
US$24,519 		4,697 5.22 US$24,519
2026-04-23 2026-04-23 PrS Proposed sale
3.7
YERXA BENJAMIN R

Officer

Officer
7,470
5.24
US$39,121 		7,470 5.24 US$39,121
2026-04-23 2026-04-23 PrS Proposed sale
3.5
Magrath George

Officer

Officer
9,511
13.39
US$127,327 		9,511 13.39 US$127,327
2026-04-23 2026-04-23 PrS Proposed sale
3.1
Gagnon Robert E.

Officer

Officer
7,842
5.18
US$40,658 		7,842 5.18 US$40,658
2026-04-23 2026-04-23 PrS Proposed sale
3.3
Jayagopal Ashwath

Officer

Officer
7,542
5.19
US$39,156 		7,542 5.19 US$39,156
2026-03-18 2026-03-16 S Sale
3.2
Zaremba Rabourn Amy

Head of Fin. Quality Assurance

Officer
2,816 -1.5%
5.25
US$14,770 		2,816 -1.5% 5.25 US$14,770
2026-03-18 2026-03-16 S Sale
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
3,719 -1.2%
5.25
US$19,525 		3,719 -1.2% 5.25 US$19,525
2026-03-18 2026-03-16 S Sale
3.5
Magrath George

Chief Executive Officer

Executive Director
24,438 -1.4%
5.21
US$127,327 		24,438 -1.4% 5.21 US$127,327
2026-03-18 2026-03-16 S Sale
3.3
Jayagopal Ashwath

Chief Scientific & Dev. Ofc.

Officer
3,719 -0.7%
5.12
US$19,046 		3,719 -0.7% 5.12 US$19,046
2026-03-16 2026-03-16 PrS Proposed sale
3.5
Magrath George

Officer

Officer
24,438
5.21
US$127,327 		24,438 5.21 US$127,327
2025-12-31 2025-12-29 B Purchase
3.4
Gallagher Cam
Non-Executive Director
83,000 +inf%
1.97
US$163,419 		83,000 +inf% 1.97 US$163,419
2025-12-31 2025-12-29 B Purchase
3.4
Gallagher Cam
Non-Executive Director
81,000 +4.5%
1.98
US$160,275 		81,000 +4.5% 1.98 US$160,275
2025-12-11 2025-12-09 S Sale
2.2
Foundation Fighting Blindness Retinal Degeneration Fund

See Remarks

Non-Executive Director
4,000,000 -42.1%
2.15
US$8,600,000 		4,000,000 -42.1% 2.15 US$8,600,000
2024-12-30 2024-12-26 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
100,000 +20.0%
0.98
US$97,600 		100,000 +20.0% 0.98 US$97,600
2024-11-25 2024-11-21 B Purchase
3.7
YERXA BENJAMIN R

President

Executive Director
10,000 +3.0%
0.98
US$9,834 		10,000 +3.0% 0.98 US$9,834
2024-11-19 2024-11-18 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
9,706 +2.0%
1.02
US$9,943 		9,706 +2.0% 1.02 US$9,943
2024-11-19 2024-11-15 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
90,294 +23.0%
1.01
US$91,215 		90,294 +23.0% 1.01 US$91,215
2024-05-24 2024-05-22 B Purchase
3.3
Jayagopal Ashwath

Chief Scientific & Dev. Ofc.

Officer
3,500 +4.7%
1.77
US$6,178 		3,500 +4.7% 1.77 US$6,178
2024-05-21 2024-05-17 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
5,000 +1.2%
1.75
US$8,772 		5,000 +1.2% 1.75 US$8,772
2024-05-21 2024-05-17 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
5,000 +1.2%
1.75
US$8,772 		5,000 +1.2% 1.75 US$8,772
2024-03-25 2024-03-21 B Purchase
0.7
Jhaveri Nirav S.

Chief Financial Officer

Officer
10,000 +7.1%
2.10
US$21,000 		10,000 +7.1% 2.10 US$21,000
2024-03-25 2024-03-21 B Purchase
3.1
SCHACHLE JOSEPH K

Chief Operating Officer

Officer
2,000 +inf%
2.05
US$4,100 		2,000 +inf% 2.05 US$4,100
2024-03-20 2024-03-18 B Purchase
3.5
Magrath George

Chief Executive Officer

Officer
25,000 +6.2%
1.96
US$49,050 		25,000 +6.2% 1.96 US$49,050
2022-05-24 2022-05-20 B Purchase
3.4
MANUSO JAMES S J
Non-Executive Director
5,000 +30.2%
1.99
US$9,950 		5,000 +30.2% 1.99 US$9,950
2022-05-23 2022-05-20 B Purchase
2.8
Sooch Mina

President and CEO

Executive Director
12,500 +3.0%
2.02
US$25,300 		12,500 +3.0% 2.02 US$25,300
2022-05-23 2022-05-19 B Purchase
2.8
Sooch Mina

President and CEO

Executive Director
12,500 +3.1%
2.07
US$25,879 		12,500 +3.1% 2.07 US$25,879
2021-12-14 2021-12-13 B Purchase
1.4
Pepose Jay
Non-Executive Director
8,250 +56.0%
3.65
US$30,112 		8,250 +56.0% 3.65 US$30,112
2021-11-22 2021-11-18 B Purchase
3.4
MANUSO JAMES S J
Non-Executive Director
2,000 +13.7%
3.50
US$7,000 		2,000 +13.7% 3.50 US$7,000
2020-11-25 2020-11-19 B Purchase
3.4
Gallagher Cam
Non-Executive Director
8,865
0.00
US$0 		8,865 0.00 US$0
2020-11-25 2020-11-19 B Purchase
3.4
MANUSO JAMES S J
Non-Executive Director
4,434
0.00
US$0 		4,434 0.00 US$0
2020-11-25 2020-11-19 B Purchase
2.8
Sooch Mina

President and CEO

Executive Director
11,524
0.00
US$0 		11,524 0.00 US$0
2020-11-25 2020-11-19 B Purchase
Rodgers Richard J
Non-Executive Director
17,730
0.00
US$0 		17,730 0.00 US$0
2020-11-25 2020-11-19 B Purchase
Ainsworth Sean
Non-Executive Director
8,865
0.00
US$0 		8,865 0.00 US$0
2020-11-25 2020-11-19 B Purchase
MEYER ALAN R
Non-Executive Director
1,771
0.00
US$0 		1,771 0.00 US$0
2019-02-04 2019-01-31 B Purchase
0.6
Beever Charles
10,000 +1000.0%
0.64
US$6,380 		10,000 +1000.0% 0.64 US$6,380
2019-01-31 2019-01-30 B Purchase
0.6
Nolan Lisa

Chief Business Officer
20,000 +1230.8%
0.65
US$12,960 		20,000 +1230.8% 0.65 US$12,960
2019-01-31 2019-01-29 B Purchase
0.6
Price Ben Gil
15,000 +inf%
0.61
US$9,141 		15,000 +inf% 0.61 US$9,141
2019-01-30 2019-01-29 B Purchase
1.2
Swirsky Douglas J

President and CEO
50,000 +inf%
0.63
US$31,720 		50,000 +inf% 0.63 US$31,720
2017-04-12 2017-04-10 PlS Planned sale Ahn Chang Ho
250,000 -4.0%
0.70
US$175,375 		250,000 -4.0% 0.70 US$175,375
2015-01-12 2015-01-12 PlS Planned sale Jeong Tae Heum

Chief Financial Officer

Officer
49,800 -9.0%
0.91
US$45,492 		49,800 -9.0% 0.91 US$45,492
2015-01-12 2015-01-12 PlS Planned sale Ahn Chang Ho Non-Executive Director
48,444 -0.8%
0.91
US$44,263 		48,444 -0.8% 0.91 US$44,263
2015-01-12 2015-01-09 PlS Planned sale Jeong Tae Heum

Chief Financial Officer

Officer
188,690 -27.2%
0.92
US$172,708 		188,690 -27.2% 0.92 US$172,708
2015-01-12 2015-01-09 PlS Planned sale Ahn Chang Ho Non-Executive Director
186,212 -3.0%
0.92
US$170,477 		186,212 -3.0% 0.92 US$170,477
2015-01-12 2015-01-08 PlS Planned sale Jeong Tae Heum

Chief Financial Officer

Officer
78,782 -13.5%
0.90
US$70,935 		78,782 -13.5% 0.90 US$70,935
2015-01-12 2015-01-08 PlS Planned sale Ahn Chang Ho Non-Executive Director
80,000 -1.3%
0.90
US$72,032 		80,000 -1.3% 0.90 US$72,032
2014-06-16 2014-06-12 S Sale Ahn Chang Ho Non-Executive Director
136,193 -2.0%
0.99
US$134,436 		136,193 -2.0% 0.99 US$134,436
2013-09-11 2013-09-09 S Sale Jeong Tae Heum

Chief Financial Officer

Officer
71,139 -12.3%
0.46
US$32,475 		71,139 -12.3% 0.46 US$32,475
2011-10-21 2011-10-03 B Purchase Kivel Richard Non-Executive Director
2,500 +inf%
1.04
US$2,600 		2,500 +inf% 1.04 US$2,600
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
5,000 +3.4%
1.23
US$6,150 		5,000 +3.4% 1.23 US$6,150
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
13,300 +10.1%
1.22
US$16,213 		13,300 +10.1% 1.22 US$16,213
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
55,100 +71.9%
1.22
US$67,222 		55,100 +71.9% 1.22 US$67,222
2011-09-12 2011-09-09 B Purchase Brandt Peter C. Non-Executive Director
6,600 +9.4%
1.21
US$7,986 		6,600 +9.4% 1.21 US$7,986
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
15,000 +27.3%
1.08
US$16,185 		15,000 +27.3% 1.08 US$16,185
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
2,500 +4.8%
1.10
US$2,748 		2,500 +4.8% 1.10 US$2,748
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
5,912 +12.7%
1.09
US$6,444 		5,912 +12.7% 1.09 US$6,444
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
13,800 +42.1%
1.10
US$15,180 		13,800 +42.1% 1.10 US$15,180
2011-09-12 2011-09-08 B Purchase Brandt Peter C. Non-Executive Director
7,200 +28.1%
1.12
US$8,064 		7,200 +28.1% 1.12 US$8,064
Explore more

More insider trading research around Opus Genetics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America